Milann first hospital to get ICMR approval for uterus transplant
Bangalore-based Milann, one of the leading fertility centres in India, has become the first hospital in the country to receive […]
DRUG-CONTROLLER-GENERAL
Govt warns firms creating artificial shortage of stents
The government has warned stringent action against companies that are trying to create an artificial shortage of life-saving coronary stents […]
IMA to collate list of ‘unsafe’ combination medicines
The Indian Medical Association (IMA), a national voluntary body representing 2.7 lakh doctors in India, will collate a list of […]
Drugs and Cosmetics Bill, 2015
The Ministry of Health and Family Welfare has invited feedback on the draft Drugs and Cosmetics Bill. The Centre would […]
WHO Clears Indian Drug Vetting System
Had the Indian drug vetting system flunked the test again, it would have jeopardised the fate of exports of Indian […]
DCGI Plans Drug Alert System
This is the first concerted attempt to develop a pan-India drug alert system for consumers, which some states like Gujarat […]
Opto Circuits Launches Heart Device for Indian Market
Opto Eurocor Healthcare, a subsidiary of Opto Circuits (India), launched Sirolimus Drug Eluting Stent (DES), E-Magic Plus on receipt of […]
Piramal Healthcare Gets Green Signal for Phase II Trials of Cancer Drug
Piramal Healthcare has received approval from the Drug Controller General of India to conduct Phase-II clinical trials of the cancer […]
Sms to check authenticity of drug
There is good news for all who are worried that the pill we consume might be spurious.
DCGI Banned Vicks Action 500 and D Cold
Drug Controller General of India (DCGI) has banned popular medicines, declaring them
Gujarat’s Zydus Cadila to make India’s First H1N1 shot
The Ahmedabad-based pharmaceutical company, Zydus Cadila, could be the first Indian company to develop a vaccine for swine flu.
Cadila expects Rs 100-cr revenue from Policap
Ahmedabad-based Cadila Pharmaceuticals on Saturday said it is expecting a revenue of INR 100 crore from the sale of its patented combination drug, Policap, which it expects to launch by the middle of next month.
